413PClinical benefits of later line trabectedin and eribulin treatment for soft tissue sarcoma (STS) after pazopanib treatment from the Nishinomiya Sarcoma Cohort Study (NSCS)Narahara, H; Morimoto, M; Tanaka, E; Ueda, S; Yasunaga, Y; Inui, Y; Takahashi, K; Kawata, S · Annals of Oncology · 2018

ISY-13-3The clinical outcome of pazopanib treatment for soft tissue sarcomas: A Japanese Musculoskeletal Oncology Group studyMatsumine , Akihiko; Nakamura , Tomoki; Kawai , Akira; Araki , Nobuhito; Goto , Takahiro; Yonemoto , Tsukasa; Sugiura , Hideshi; Nishida , Yoshihiro; Hiraga , Hiroaki; Ueda , Takafumi · Annals of Oncology · 2016

Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)Sleijfer, S.; Ray-Coquard, I.; Papai, Z.; Le Cesne, A.; Scurr, M.; Schoffski, P.; Collin, F.; Pandite, L.; Marreaud, S.; De Brauwer, A.; van Glabbeke, M.; Verweij, J.; Blay, J.-Y. · Journal of Clinical Oncology · 2009

Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue SarcomaKim, Jee Hung; Park, Hyung Soon; Heo, Su Jin; Kim, Sang Kyum; Han, Jung Woo; Shin, Kyoo-Ho; Kim, Seung Hyun; Hur, Hyuk; Kim, Kyung Sik; Choi, Young Deuk; Kim, Sunghoon; Lee, Young Han; Suh, Jin-Suck; Ahn, Joong-Bae; Chung, Hyun Cheol; Noh, Sung Hoon; Rha, Sun Young; Kim, Hyo Song · Oncology · 2018

A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue SarcomasMunhoz, R. R.; D'Angelo, S. P.; Gounder, M. M.; Keohan, M. L.; Chi, P.; Carvajal, R. D.; Singer, S.; Crago, A. M.; Landa, J.; Healey, J. H.; Qin, L.-X.; Hameed, M.; Ezeoke, M. O.; Singh, A. S.; Agulnik, M.; Chmielowski, B.; Luke, J. J.; Van Tine, B. A.; Schwartz, G. K.; Tap, W. D.; Dickson, M. A. · The Oncologist · 2015

Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluationTanaka, Kazuhiro; Kawano, Masanori; Iwasaki, Tatsuya; Itonaga, Ichiro; Tsumura, Hiroshi · BMC Cancer · 2019

Association of pazopanib-induced toxicities with outcome of patients with advanced soft tissue sarcoma; a retrospective analysis based on the European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 clinical trialsVos, Melissa; Sleijfer, Stefan; Litière, Saskia; Touati, Nathan; Duffaud, Florence; van der Graaf, Winette T.; Gelderblom, Hans · Acta Oncologica · 2019

Melatonergic drugs in developmentCarocci, Alessia; Catalano, Alessia; Sinicropi, Maria Stefania · Clinical Pharmacology: Advances and Applications · 2014

Synthetic cathinone abuseCapriola, Michael · Clinical Pharmacology: Advances and Applications · 2013

Managing insulin resistance: role of liraglutideSharma, · Clinical Pharmacology: Advances and Applications · 2010

Testosterone replacement in male hypogonadismSharma, · Clinical Pharmacology: Advances and Applications · 2010

Smoking cessationKaur, Kirandeep; Juneja, ; Kaushal, · Clinical Pharmacology: Advances and Applications · 2012

ErratumTaglialatela, Maurizio; Barrese, V; Miceli, ; Soldovieri, Maria; Ambrosino, Paolo; Iannotti, Fabio; Cilio, Roberta · Clinical Pharmacology: Advances and Applications · 2012

Sedation in the intensive care settingPandharipande, Pratik; Hughes, ; McGrane, · Clinical Pharmacology: Advances and Applications · 2012

Arginine deprivation therapy for malignant melanomaKim, Kevin; Yoon, ; Frankel, Arthur; Feun, ; Ekmekcioglu, · Clinical Pharmacology: Advances and Applications · 2012